We are live on
!
Find out more
GC
Grace Capital Portfolio holdings
AUM
$168M
1-Year Est. Return
21.6%
This Fund
S&P 500
This Quarter
Est. Return
+26.52%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$116M
AUM Growth
+$14.7M
(+14%)
Cap. Flow
-$9.16M
Cap. Flow
% of AUM
-7.87%
Top 10 Holdings %
Top 10 Hldgs %
31.04%
Holding
223
New
42
Increased
28
Reduced
50
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$1.48M |
| 2 |
BridgeBio Pharma
BBIO
|
+$1.22M |
| 3 |
TD Synnex
SNX
|
+$822K |
| 4 |
State Street SPDR Bloomberg Convertible Securities ETF
CWB
|
+$749K |
| 5 |
Sphere Entertainment
SPHR
|
+$692K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$2.09M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$2.05M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.75M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.51M |
| 5 |
Apple
AAPL
|
+$948K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.5% |
| 2 | Technology | 12.36% |
| 3 | Financials | 12.22% |
| 4 | Consumer Discretionary | 8.47% |
| 5 | Communication Services | 5.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $8.75M | 7.52% |
138,649
-7,780
| -5% | -$534K |
|
2
Safety Insurance
SAFT
$1.09B
| $6.08M | 5.22% |
79,687
+4,000
| +5% | +$313K |
|
3
Amazon
AMZN
$2.66T
| $3.76M | 3.23% |
27,280
-1,760
| -6% | -$213K |
|
|
4
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $2.53M | 2.17% |
8,210
-5,150
| -39% | -$1.51M |
|
|
5
BridgeBio Pharma
BBIO
$15.9B
| $2.43M | 2.08% |
74,425
+39,925
| +116% | +$1.22M |
|
|
MYOK
6
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $2.36M | 2.02% |
24,400
-25,100
| -51% | -$2.09M |
|
|
PTLA
7
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.3M | 1.97% |
127,729
-147,103
| -54% | -$2.05M |
|
8
Texas Pacific Land
TPL
$28.7B
| $2.26M | 1.94% |
34,200
+2,700
| +9% | +$166K |
|
|
DAY
9
DELISTED
Dayforce
DAY
| $2.16M | 1.85% |
27,200
-5,900
| -18% | -$379K |
|
10
Visa
V
$682B
| $2.15M | 1.85% |
11,145
-2,127
| -16% | -$389K |
|
11
Meta Platforms (Facebook)
META
$1.64T
| $2.13M | 1.83% |
9,400
+300
| +3% | +$62.6K |
|
|
12
Alphabet (Google) Class A
GOOGL
$4.23T
| $1.98M | 1.7% |
+22,000
| New | +$1.48M |
|
13
Eli Lilly
LLY
$1.05T
| $1.73M | 1.48% |
10,518
| – | – |
|
14
Alibaba
BABA
$276B
| $1.7M | 1.46% |
7,900
+400
| +5% | +$83.3K |
|
15
Ares Capital
ARCC
$13.8B
| $1.55M | 1.33% |
107,500
+24,700
| +30% | +$333K |
|
16
Vanguard Mega Cap Growth ETF
MGK
$32.7B
| $1.55M | 1.33% |
47,500
+11,500
| +32% | +$343K |
|
|
17
Apple
AAPL
$4.9T
| $1.53M | 1.31% |
16,776
-12,232
| -42% | -$948K |
|
18
iShares Core S&P 500 ETF
IVV
$881B
| $1.5M | 1.29% |
4,850
+110
| +2% | +$32.3K |
|
19
Berkshire Hathaway Class A
BRK.A
$1.06T
| $1.34M | 1.15% |
5
-1
| -17% | -$274K |
|
20
iShares US Consumer Staples ETF
IYK
$1.39B
| $1.28M | 1.1% |
30,000
| – | – |
|
21
CVS Health
CVS
$137B
| $1.26M | 1.08% |
19,372
+2,900
| +18% | +$183K |
|
22
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.07B
| $1.22M | 1.05% |
40,000
| – | – |
|
23
Gilead Sciences
GILD
$167B
| $1.21M | 1.04% |
15,700
-2,000
| -11% | -$153K |
|
24
Microsoft
MSFT
$2.93T
| $1.19M | 1.02% |
5,850
-4,364
| -43% | -$792K |
|
25
MongoDB
MDB
$25.1B
| $1.13M | 0.97% |
15,000
| – | – |
|
Similar funds
REMS
TI
NM
KM
MC
FAC
MSO
ACM
Grace Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Grace Capital held 223 positions worth $116M, up 14% from $102M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Grace Capital withdrew a net $9.16M in Q2 2020, closing 9 positions and reducing 50 holdings. Its most notable exit was Vanguard Information Technology ETF, an estimated $684K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
Against the trend, Grace Capital opened a new position in Alphabet (Google) Class A worth $1.98M.
- Grace Capital's largest Q2 2020 buy was Alphabet (Google) Class A: 22,000 shares worth $1.98M.
- Grace Capital added most to BridgeBio Pharma in Q2 2020, an estimated $1.22M increase.
- Grace Capital's biggest Q2 2020 reduction was MyoKardia, Inc. Common Stock, cutting an estimated $2.09M.
- Grace Capital fully exited Vanguard Information Technology ETF in Q2 2020, selling an estimated $684K.
- Grace Capital's ten largest holdings make up 31% of its $116M portfolio in Q2 2020.
- Grace Capital opened 42 new positions and closed 9 in Q2 2020.
- Grace Capital's portfolio value rose 14% quarter-over-quarter to $116M.
Based on Grace Capital's 13F filing for Q2 2020, filed 13 Aug 2020.